UK markets closed

PainReform Ltd. (PRFX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.7800-0.0189 (-2.37%)
At close: 04:00PM EDT
0.7800 0.00 (0.00%)
After hours: 04:49PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.93M
Enterprise value -6.01M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.27
Enterprise value/revenue N/A
Enterprise value/EBITDA -2.32

Trading information

Stock price history

Beta (5Y monthly) 0.73
52-week change 329.35%
S&P500 52-week change 326.27%
52-week high 326.4100
52-week low 30.4170
50-day moving average 31.4407
200-day moving average 32.7474

Share statistics

Avg vol (3-month) 3145.15k
Avg vol (10-day) 327.92k
Shares outstanding 52.47M
Implied shares outstanding 62.47M
Float 81.3M
% held by insiders 18.82%
% held by institutions 120.37%
Shares short (30 Apr 2024) 419.81k
Short ratio (30 Apr 2024) 40.05
Short % of float (30 Apr 2024) 40.93%
Short % of shares outstanding (30 Apr 2024) 40.80%
Shares short (prior month 28 Mar 2024) 416.44k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 303 Jul 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-53.82%
Return on equity (ttm)-102.34%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -9.57M
Net income avi to common (ttm)-9.34M
Diluted EPS (ttm)-7.1400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.03M
Total cash per share (mrq)4.64
Total debt (mrq)86k
Total debt/equity (mrq)1.19%
Current ratio (mrq)4.07
Book value per share (mrq)4.19

Cash flow statement

Operating cash flow (ttm)-6.68M
Levered free cash flow (ttm)-3.56M